Adam Jaffé

9.9k total citations
250 papers, 6.0k citations indexed

About

Adam Jaffé is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Adam Jaffé has authored 250 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Pulmonary and Respiratory Medicine, 51 papers in Epidemiology and 50 papers in Physiology. Recurrent topics in Adam Jaffé's work include Cystic Fibrosis Research Advances (93 papers), Neonatal Respiratory Health Research (65 papers) and Asthma and respiratory diseases (43 papers). Adam Jaffé is often cited by papers focused on Cystic Fibrosis Research Advances (93 papers), Neonatal Respiratory Health Research (65 papers) and Asthma and respiratory diseases (43 papers). Adam Jaffé collaborates with scholars based in Australia, United Kingdom and United States. Adam Jaffé's co-authors include Andrew Bush, Nusrat Homaira, Samatha Sonnappa, Chee Y. Ooi, Tamarah Katz, Hemamala I. Karunadasa, Roxanne Strachan, Charles F. Verge, Yvonne Belessis and Tom Snelling and has published in prestigious journals such as Gastroenterology, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Adam Jaffé

238 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Jaffé Australia 41 3.4k 1.3k 853 634 586 250 6.0k
John Edelsberg United States 44 2.2k 0.7× 1.6k 1.2× 1.1k 1.2× 566 0.9× 834 1.4× 118 8.1k
Patrick A. Flume United States 47 7.8k 2.3× 1.7k 1.3× 801 0.9× 1.0k 1.7× 800 1.4× 241 9.6k
Jareen Meinzen‐Derr United States 42 1.6k 0.5× 1.5k 1.2× 731 0.9× 434 0.7× 495 0.8× 195 7.1k
Dominic A. Fitzgerald Australia 40 2.6k 0.8× 852 0.7× 1.1k 1.3× 200 0.3× 871 1.5× 210 4.6k
Cornelis K. van der Ent Netherlands 46 5.3k 1.6× 1.5k 1.2× 810 0.9× 2.0k 3.2× 1.7k 2.9× 310 9.9k
Alan R Smyth United Kingdom 43 4.0k 1.2× 1.9k 1.5× 354 0.4× 1.2k 2.0× 706 1.2× 225 7.2k
Karen McCoy United States 38 4.7k 1.4× 890 0.7× 554 0.6× 1.2k 1.8× 650 1.1× 153 6.3k
Eitan Kerem Israel 50 7.1k 2.1× 1.4k 1.1× 1.2k 1.4× 1.8k 2.8× 1.1k 1.8× 263 10.0k
Peter J. Mogayzel United States 29 3.4k 1.0× 839 0.7× 446 0.5× 460 0.7× 434 0.7× 110 4.5k
Jeffrey S. Wagener United States 41 5.2k 1.5× 926 0.7× 364 0.4× 845 1.3× 663 1.1× 98 6.3k

Countries citing papers authored by Adam Jaffé

Since Specialization
Citations

This map shows the geographic impact of Adam Jaffé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Jaffé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Jaffé more than expected).

Fields of papers citing papers by Adam Jaffé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Jaffé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Jaffé. The network helps show where Adam Jaffé may publish in the future.

Co-authorship network of co-authors of Adam Jaffé

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Jaffé. A scholar is included among the top collaborators of Adam Jaffé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Jaffé. Adam Jaffé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Mei, Nan Hu, Brendan McMullan, et al.. (2024). Clinical Characteristics and In-hospital Outcomes Associated With Respiratory Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized Children Younger Than 2 Years. The Journal of Infectious Diseases. 231(5). 1309–1317. 1 indexed citations
2.
Chan, Mei, et al.. (2023). Asthma and Susceptibility to COVID-19 in Australian Children During Alpha, Delta and Omicron Waves of the COVID-19 Pandemic. Journal of Asthma and Allergy. Volume 16. 1139–1155. 3 indexed citations
3.
Xu, Shuting, Ravinesh C. Deo, Jeffrey Soar, et al.. (2023). Automated detection of airflow obstructive diseases: A systematic review of the last decade (2013-2022). Computer Methods and Programs in Biomedicine. 241. 107746–107746. 5 indexed citations
4.
Schultz, André, et al.. (2023). Learning to make a difference for chILD: Value creation through network collaboration and team science. Pediatric Pulmonology. 59(9). 2257–2266. 4 indexed citations
5.
Wong, Sharon L., et al.. (2023). Molecular and Functional Characteristics of Airway Epithelium under Chronic Hypoxia. International Journal of Molecular Sciences. 24(7). 6475–6475. 4 indexed citations
6.
Kelada, Lauren, Claire E. Wakefield, David Armstrong, et al.. (2022). Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life. BMJ Open Respiratory Research. 9(1). e001139–e001139. 2 indexed citations
7.
Hibbert, Peter, W. B. Runciman, Andrew Carson‐Stevens, et al.. (2020). Characterising the types of paediatric adverse events detected by the global trigger tool – CareTrack Kids. Journal of Patient Safety and Risk Management. 25(6). 239–249. 3 indexed citations
8.
Wakefield, Claire E., Sheila Sivam, Peter G. Middleton, et al.. (2020). Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions. ERJ Open Research. 7(1). 448–2020. 8 indexed citations
9.
Coffey, Michael J., Ivan Cherh Chiet Low, Sacha Stelzer‐Braid, et al.. (2020). The intestinal virome in children with cystic fibrosis differs from healthy controls. PLoS ONE. 15(5). e0233557–e0233557. 13 indexed citations
10.
Homaira, Nusrat, Louise Wiles, Claire Gardner, et al.. (2019). Assessing the quality of health care in the management of bronchiolitis in Australian children: a population-based sample survey. BMJ Quality & Safety. 28(10). 817–825. 7 indexed citations
11.
Bhuiyan, Mejbah, Tom Snelling, Rachel Marceau West, et al.. (2018). Role of viral and bacterial pathogens in causing pneumonia among Western Australian children: a case–control study protocol. BMJ Open. 8(3). e020646–e020646. 21 indexed citations
12.
Hibbert, Peter, Andrew R. Hallahan, Stephen E. Muething, et al.. (2015). CareTrack Kids—part 3. Adverse events in children's healthcare in Australia: study protocol for a retrospective medical record review. BMJ Open. 5(4). e007750–e007750. 9 indexed citations
13.
Wiles, Louise, T. Hooper, Peter Hibbert, et al.. (2015). CareTrack Kids—part 1. Assessing the appropriateness of healthcare delivered to Australian children: study protocol for clinical indicator development. BMJ Open. 5(4). e007748–e007748. 33 indexed citations
14.
Katz, Tamarah, et al.. (2014). Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis. Journal of Clinical Pathology. 67(7). 605–608. 42 indexed citations
15.
Strachan, Roxanne, Tanya Gulliver, A. Andrés Martín, et al.. (2011). Paediatric empyema thoracis: Recommendations for management. Queensland's institutional digital repository (The University of Queensland). 5 indexed citations
16.
Hameed, Shihab A., Adam Jaffé, & Charles F. Verge. (2011). Cystic Fibrosis Related Diabetes (CFRD)—The End Stage of Progressive Insulin Deficiency. Pediatric Pulmonology. 46(8). 747–760. 40 indexed citations
17.
Sonnappa, Samatha & Adam Jaffé. (2008). Treatment approaches for empyema in children (vol 8 pg 164, 2007). UCL Discovery (University College London). 1 indexed citations
18.
Sonnappa, Samatha, Gordon Cohen, Cátherine M. Owens, et al.. (2006). Comparison of Urokinase and Video-assisted Thoracoscopic Surgery for Treatment of Childhood Empyema. American Journal of Respiratory and Critical Care Medicine. 174(2). 221–227. 231 indexed citations
19.
Davies, Jane C., Michael Davies, Adam Jaffé, et al.. (2005). Potential Difference Measurements in the Lower Airway of Children with and without Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 171(9). 1015–1019. 28 indexed citations
20.
Jaffé, Adam & Ian M. Balfour‐Lynn. (2002). Treatment of Severe Small Airways Disease in Children with Cystic Fibrosis. Pediatric Drugs. 4(6). 381–389. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Edelsberg Breakdown of academic impact, for papers by Patrick A. Flume Breakdown of academic impact, for papers by Jareen Meinzen‐Derr Breakdown of academic impact, for papers by Dominic A. Fitzgerald Breakdown of academic impact, for papers by Cornelis K. van der Ent Breakdown of academic impact, for papers by Alan R Smyth Breakdown of academic impact, for papers by Karen McCoy Breakdown of academic impact, for papers by Eitan Kerem Breakdown of academic impact, for papers by Peter J. Mogayzel Breakdown of academic impact, for papers by Jeffrey S. Wagener
Rankless by CCL
2026